NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ruhan Gene Tech

Ruhan Gene Tech

Private
ShenzhenHealthcare & Life Scienceshttps://www.rhgenetech.com/

Last Round

Angel

Sep 6, 2021

Company Overview

Ruhan Gene Tech is a biotechnology company that develops fourth-generation gene sequencing equipment and nanopore-based virus detection systems for medical and public health applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

nanopore sequencingpathogen detectiongenomic sequencingvirus identificationclinical diagnosticsepidemic preventionPOCTpoint-of-care testingrapid testingfourth-generation sequencingportable diagnosticsbiosurveillancebiotech hardwarebase-callingmacromolecule detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ruhan Gene Tech Comparables

Compare Ruhan Gene Tech with similar companies based on industry and business-model similarity.

Ruhan Gene Tech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Geneus Technologies (Chengdu) Co., Ltd.
83%
Qitan Tech
79%
Oxford Nanopore Technologies plc
72%

Ruhan Gene Tech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelSep 6, 2021
SeedDec 1, 2019

Ruhan Gene Tech Investors

Notable investors and investment history

Ruhan Gene Tech investors
InvestorRounds
Shenzhen Leaguer Venture CapitalAngel
Hengbang CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 6, 2021

    Led by Shenzhen Leaguer Venture Capital

  • Dec 1, 2019

    Hengbang Capital participated in the Seed round.

Ruhan Gene Tech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ruhan Gene Tech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ruhan Gene Tech's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2019
Last FundingSep 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.